Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-21-019718
Filing Date
2021-08-13
Accepted
2021-08-13 16:16:11
Documents
38
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 335372
2 ex31-1.htm EX-31.1 17342
3 ex32-1.htm EX-32.1 6660
  Complete submission text file 0001493152-21-019718.txt   1749849

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE glsi-20210630.xsd EX-101.SCH 16284
5 XBRL CALCULATION FILE glsi-20210630_cal.xml EX-101.CAL 23166
6 XBRL DEFINITION FILE glsi-20210630_def.xml EX-101.DEF 58392
7 XBRL LABEL FILE glsi-20210630_lab.xml EX-101.LAB 138053
8 XBRL PRESENTATION FILE glsi-20210630_pre.xml EX-101.PRE 112113
9 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 156892
Mailing Address 3992 BLUEBONNET DR, BUILDING 14 STAFFORD TX 77477
Business Address 3992 BLUEBONNET DR, BUILDING 14 STAFFORD TX 77477 203-434-3290
Greenwich LifeSciences, Inc. (Filer) CIK: 0001799788 (see all company filings)

EIN.: 205473709 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39555 | Film No.: 211172349
SIC: 2834 Pharmaceutical Preparations